Na Li

Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2

Hui Wang, Yuntao Zhang, Baoying Huang et al. · Cell · 2020 · 801 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery

Li Tang, Yiran Zheng, Mariane B. Melo et al. · Nature Biotechnology · 2018 · 646 citations · Full text

Pharmacy, Immunology, Pharmaceutics +14

Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice

Xiaojun Liu, Shuguang Jiang, Chongyun Fang et al. · Cancer Research · 2015 · 566 citations · Full text

Medicine, Immunology, Oncology +17

Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastoma

Laura A. Johnson, John Scholler, Takayuki Ohkuri et al. · Science Translational Medicine · 2015 · 453 citations

Medicine, Immunology, Oncology +16

Enhanced CAR–T cell activity against solid tumors by vaccine boosting through the chimeric receptor

Leyuan Ma, Tanmay Dichwalkar, Jason Y.H. Chang et al. · Science · 2019 · 431 citations · Full text

Medicine, Immunology, Oncology +17